Concit Pharma paricipated in the Danish Life Sciences Investor Forum in New York on 30.09.2013 to 02.10.2013.
Concit Pharma in NY
Recent News
November 28, 2024
Contera Pharma announces first patient dosed in Phase 1b trial of CP-012, a novel therapy to treat nocturnal immobility and morning akinesia in Parkinson’s disease
Contera Pharma A/S, a clinical-stage biotech company pioneering innovative treatments for neurological disorders, has announced the dosing of the first patient in…
Read more
October 18, 2024
Contera Pharma A/S closes Korean office and consolidates all activities in Denmark – 2nd announcement
Notice of Dissolution and Filing of Claims Contera Pharma A/S has decided to close the branch office in Korea and consolidate all…
Read more
Contact us
Contera Pharma Headquarter
Contera Pharma A/S
Venlighedsvej 4
2970 Hørsholm
Denmark
Thomas Sager, CEO
info@conterapharma.com
